These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29611885)

  • 1. Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: a monocentre assessment.
    Frau J; Coghe G; Casanova P; Sardu C; Lorefice L; Fenu G; Marrosu MG; Cocco E
    Eur J Neurol; 2018 Aug; 25(8):1063-1068. PubMed ID: 29611885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
    Zipoli V; Portaccio E; Hakiki B; Siracusa G; Sorbi S; Amato MP
    J Neurol Sci; 2008 Mar; 266(1-2):25-30. PubMed ID: 17870094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.
    Cocco E; Sardu C; Gallo P; Capra R; Amato MP; Trojano M; Uccelli A; Marrosu MG;
    Mult Scler; 2008 Nov; 14(9):1225-33. PubMed ID: 18701568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis.
    Ghalie RG; Mauch E; Edan G; Hartung HP; Gonsette RE; Eisenmann S; Le Page E; Butine MD; De Goodkin DE
    Mult Scler; 2002 Oct; 8(5):441-5. PubMed ID: 12356214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
    Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
    BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.
    Ghalie RG; Edan G; Laurent M; Mauch E; Eisenman S; Hartung HP; Gonsette RE; Butine MD; Goodkin DE
    Neurology; 2002 Sep; 59(6):909-13. PubMed ID: 12297576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
    Friend S; Richman S; Bloomgren G; Cristiano LM; Wenten M
    BMC Neurol; 2016 Aug; 16(1):150. PubMed ID: 27552976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Singhal BS; Geeta S; Hundalani SG; Menon S
    Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study.
    Funch D; Norman H; Wong J; Bennett R; Hillier J; Al-Sabbagh A; Seeger JD
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):448-56. PubMed ID: 20333778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
    Sandberg-Wollheim M; Frank D; Goodwin TM; Giesser B; Lopez-Bresnahan M; Stam-Moraga M; Chang P; Francis GS
    Neurology; 2005 Sep; 65(6):802-6. PubMed ID: 16093457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone reduced disability in Iranian patients with multiple sclerosis.
    Hamzehloo A; Etemadifar M
    Arch Iran Med; 2007 Jan; 10(1):59-64. PubMed ID: 17198456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.
    Amato MP; Portaccio E; Ghezzi A; Hakiki B; Zipoli V; Martinelli V; Moiola L; Patti F; La Mantia L; Mancardi GL; Solaro C; Tola MR; Pozzilli C; De Giglio L; Totaro R; Lugaresi A; Di Tommaso V; Paolicelli D; Marrosu MG; Comi G; Pellegrini F; Trojano M;
    Neurology; 2010 Nov; 75(20):1794-802. PubMed ID: 21079181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
    Öhrfelt A; Axelsson M; Malmeström C; Novakova L; Heslegrave A; Blennow K; Lycke J; Zetterberg H
    Mult Scler; 2016 Oct; 22(12):1587-1595. PubMed ID: 26754805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
    Goffette S; van Pesch V; Vanoverschelde JL; Morandini E; Sindic CJ
    J Neurol; 2005 Oct; 252(10):1217-22. PubMed ID: 15834643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive outcomes following cesarean scar pregnancy - a case series and review of the literature.
    Gao L; Huang Z; Zhang X; Zhou N; Huang X; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():102-7. PubMed ID: 27014853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of pediatric patients treated with mitoxantrone for multiple sclerosis.
    Kornek B; Bernert G; Rostasy K; Mlczoch E; Feucht M; Prayer D; Vass K; Seidl R
    Neuropediatrics; 2011 Feb; 42(1):7-12. PubMed ID: 21557144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis.
    Sadovnick D; Criscuoli M; Yee I; Carruthers R; Schabas A; Devonshire V; Smyth P
    Mult Scler; 2023 Mar; 29(3):407-414. PubMed ID: 36683353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status.
    Ostberg A; Pittas F; Taylor B
    Intern Med J; 2005 Jul; 35(7):382-7. PubMed ID: 15958106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glatiramer acetate during early pregnancy: A prospective cohort study.
    Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.